Diane Havlir

Class-sparing regimens for initial treatment of HIV-1 infection.

Lynne Peeples, Richard Haubrich, Susan Swindells, 2008, The New England journal of medicine.

Virtual Inhibitory Quotient Predicts Response to Ritonavir Boosting of Indinavir-Based Therapy in Human Immunodeficiency Virus-Infected Patients with Ongoing Viremia

Dale J. Kempf, Joel Gallant, Richard Rode, 2002, Antimicrobial Agents and Chemotherapy.

Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.

Peter Bacchetti, Paul A Volberding, P. Volberding, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

Keiji Fukuda, Mark A. Jacobson, Cynthia L. Sears, 2002 .

Prevention of HIV-1 infection with early antiretroviral therapy.

Lei Wang, David Burns, Kenneth H Mayer, 2011, The New England journal of medicine.

Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity.

Susan Little, Douglas Richman, D. Richman, 2009, Virology.

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Kenneth H Mayer, Ian Sanne, Max Essex, 2014, The Lancet. Infectious diseases.